Allspring Global Investments Holdings LLC lowered its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 63.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 25,580 shares of the company’s stock after selling 44,607 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Molina Healthcare were worth $8,814,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Innealta Capital LLC purchased a new stake in Molina Healthcare in the 2nd quarter worth $36,000. Ashton Thomas Private Wealth LLC acquired a new position in shares of Molina Healthcare during the 2nd quarter worth about $40,000. AM Squared Ltd acquired a new position in shares of Molina Healthcare during the 2nd quarter worth about $59,000. UMB Bank n.a. boosted its holdings in Molina Healthcare by 96.2% in the 3rd quarter. UMB Bank n.a. now owns 206 shares of the company’s stock worth $71,000 after buying an additional 101 shares during the last quarter. Finally, Fidelis Capital Partners LLC acquired a new stake in shares of Molina Healthcare in the first quarter worth approximately $151,000. 98.50% of the stock is owned by institutional investors and hedge funds.
Molina Healthcare Stock Performance
NYSE:MOH opened at $325.54 on Friday. Molina Healthcare, Inc. has a 52 week low of $272.69 and a 52 week high of $423.92. The company has a fifty day simple moving average of $335.23 and a two-hundred day simple moving average of $329.72. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49. The company has a market cap of $19.08 billion, a price-to-earnings ratio of 17.84, a price-to-earnings-growth ratio of 0.99 and a beta of 0.58.
Insider Transactions at Molina Healthcare
In related news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at $3,282,583.96. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the sale, the director now owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the sale, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on MOH shares. Truist Financial dropped their price target on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a research report on Monday, July 15th. TD Cowen dropped their price objective on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a report on Wednesday, July 24th. Stephens reaffirmed an “equal weight” rating and set a $320.00 target price on shares of Molina Healthcare in a research note on Thursday, July 25th. Robert W. Baird cut their price target on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating for the company in a report on Thursday. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 price objective on shares of Molina Healthcare in a report on Thursday. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $367.00.
Check Out Our Latest Stock Report on MOH
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
- Five stocks we like better than Molina Healthcare
- Stock Dividend Cuts Happen Are You Ready?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Best Stocks Under $5.00
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Invest in the FAANG Stocks
- MarketBeat Week in Review – 10/21- 10/25
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.